REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

NCT00087646 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

948

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Ribavirin
DRUG: Ribavirin
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche